BiotechTube
Home/Benitec Biopharma/Megan Boston
MB

Megan Boston

Chief Financial Officer & Director

Benitec Biopharma

Therapeutic Areas

Muscular DystrophyRare Genetic Diseases

Benitec Biopharma Pipeline

DrugIndicationPhase
BB-301Oculopharyngeal Muscular Dystrophy (OPMD)Phase 1b/2a

Leadership Team at Benitec Biopharma

JB
Jerel Banks, M.D., Ph.D.
Chief Executive Officer & Chairman of the Board
SM
Sophie Mukadam
Chief Operating Officer
JK
J. Kevin Buchi
Director
PF
Peter Francis
Director
DS
Dr. Sharon Mates
Director
View full Benitec Biopharma profile